Xilio Therapeutics, Inc. (XLO) Reports 26% Response in Colon Cancer Drug Trial
Xilio Therapeutics, Inc.
Xilio Therapeutics Inc. (XLO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 4,000,000 | $2,560,800 | 0% | |
| 2. | Sio Capital Michael Castor | 2,134,537 | $1,366,531 | 0.21% | |
| 3. | StemPoint Capital Michelle Ross | 2,030,028 | $1,299,624 | 0.22% | |
| 4. | Ghisallo Capital Management Michael Germino | 1,113,222 | $712,685 | 0.03% | |
| 5. | Citadel Investment Group Ken Griffin | 436,216 | $279,265 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 25,000 | $17,215.00 | 70,000 | 2025-06-17 | Filing | |
| $0.69 | 45,000 | $30,870.00 | 45,000 | 2025-06-16 | Filing | |
| $0.68 | 36,289 | $24,680.15 | 281,172 | 2025-06-16 | Filing | |
| $1.04 | 1,759,978 | $1,830,377.12 | 9,105,451 | 2024-12-18 | Filing | |
| $0.76 | 485,250 | $368,790.00 | 7,345,473 | 2024-04-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.64 | 1,826 | $1,174.48 | 6,371 | 2026-01-02 | Filing | |
| $0.64 | 7,030 | $4,521.70 | 24,766 | 2026-01-02 | Filing | |
| $0.98 | 6,954 | $6,840.65 | 12,421 | 2025-01-02 | Filing | |
| $0.98 | 1,803 | $1,773.61 | 3,197 | 2025-01-02 | Filing | |
| $0.64 | 267 | $170.88 | 734,546 | 2024-02-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,105,451 | $5,829,310 | 0.3% | |
| 2. | 7,372,686 | $4,719,994 | 0.36% | |
| 3. | 5,915,091 | $3,786,841 | 0.1% | |
| 4. | 1,483,758 | $949,902 | 0.34% | |
| 5. | 1,255,692 | $803,643 | 0% |
News See All
Hedge Fund Resource Center